Amass Brands flags going-concern doubt in Q3 2026
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Amass Brands reported third-quarter 2026 results, with net revenue of $5,368,515 versus $4,067,106 a year earlier. The quarter recorded a gross loss of $539,371, versus gross profit of $336,665, and net loss of $5,725,783, compared with $8,900,627. For the nine months ended September 30, 2026, revenue was $15,110,602 versus $13,912,481 and net loss was $16,316,603 versus $13,885,671.
Management said substantial doubt exists about Amass Brands’ ability to continue as a going concern within one year. At September 30, 2026, cash and cash equivalents were $818,937, the working capital deficit was $10,146,974, and operating activities used $7,612,731 during the first nine months. At that date, $550,000 of promissory notes and the Mezzanine Secured Notes were past due, while approximately $4.1 million owed under bulk-wine purchase commitments was past contractual payment dates. Nasdaq notified the company on July 22, 2026 that market-value requirements were unmet and in October 2026 of a minimum-bid-price deficiency. The company also recorded a $1,100,531 impairment of its Afterdream SAFE investment and a $1,282,510 loss on contracts in the quarter.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Hollow bars mark forward-looking points. How the balance works
Positive
- Moderate pointThird-quarter revenue was $5,368,515 versus $4,067,106 a year earlier.
- Moderate pointThird-quarter net loss was $5,725,783 versus $8,900,627 in 2025.
Negative
- Major point. Forward-looking: it has not happened yet and may not happen.Management cited substantial doubt about continued operations within one year.
- Major pointNine-month net loss was $16,316,603 versus $13,885,671 in 2025.
- Moderate pointOperating cash use was $7,612,731 versus $822,955 for the nine months ended September 30.
- Moderate point$550,000 of promissory notes and approximately $4.1 million in bulk-wine commitments were past due at September 30, 2026.
Filing Explained
September thirtieth terms indicated about twelve point eight million potential common shares from Series C; an October amendment changed the conversion terms.
At
If those common shares are issued, they would increase the share count and reduce existing holders’ percentage ownership absent offsetting changes.
The filing also reports that a separate warrant to buy up to 3.5 million common shares was terminated on
Key Figures
Key Terms
going concern financial
working capital deficit financial
Level 3 inputs technical
variable interest entity financial
beneficial ownership limitation regulatory
Simple Agreement for Future Equity financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How much revenue did AMSS report in Q3 2026?
Why did AMSS report substantial doubt about continuing as a going concern?
How many AMSS common shares were outstanding?
AI-generated analysis. How Rhea-AI works. Not financial advice.
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | |
CA | ||
(Address of principal executive offices) | (Zip Code) |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
Large accelerated filer ¨ | Accelerated filer ¨ |
x | Smaller reporting company |
Emerging growth company |
Page | ||
PART I – FINANCIAL INFORMATION | 1 | |
Item 1. | Financial Statements (Unaudited) | 1 |
Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 21 |
Item 3. | Quantitative and Qualitative Disclosures About Market Risk | 35 |
Item 4. | Controls and Procedures | 36 |
PART II – OTHER INFORMATION | 38 | |
Item 1. | Legal Proceedings | 38 |
Item 1A. | Risk Factors | 38 |
Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 39 |
Item 3. | Defaults Upon Senior Securities | 39 |
Item 4. | Mine Safety Disclosures | 39 |
Item 5. | Other Information | 39 |
Item 6. | Exhibits | 40 |
SIGNATURES | 41 | |
| i |
· | the implementation of our business model and our strategic plans for our business, product, services and technology; |
· | our commercialization and marketing capabilities and strategy; |
· | our ability to establish or maintain collaborations or strategic relationships or obtain additional funding; |
· | our competitive position; |
· | the scope of protection that we are able to establish and maintain for intellectual property rights covering our products, services and technology; |
· | developments and projections relating to our competitors and our industry; |
· | our estimates regarding expenses, future revenue, capital requirements and needs for additional financing; |
· | the period over which we estimate our existing cash and cash equivalents will be sufficient to fund our future operating expenses and capital expenditure requirements; and |
· | the impact of new or existing laws and regulations on our business and strategy. |
| ii |
Page | |
Condensed Consolidated Balance Sheets as of September 30, 2026 (Unaudited) and December 31, 2025 | 2 |
Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2026 and 2025 (Unaudited) | 3 |
Condensed Consolidated Statements of Stockholders’ Equity (Deficit) for the three and nine months ended September 30, 2026 and 2025 (Unaudited) | 4 |
Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2026 and 2025 (Unaudited) | 5 |
Notes to Condensed Consolidated Financial Statements (Unaudited) | 6 |
| 1 |
September 30, 2026 | December 31, 2025 | |||||||
Assets | ||||||||
Current Assets | ||||||||
Cash and cash equivalents | $ | $ | ||||||
Restricted cash | ||||||||
Accounts receivable, net | ||||||||
Due from related parties | ||||||||
Inventory, net | ||||||||
Interest receivable | ||||||||
Prepaid expenses and other current assets | ||||||||
Total current assets | ||||||||
Property and equipment, net | ||||||||
Intangible assets, net | ||||||||
Goodwill | ||||||||
Securities pledged as collateral, at fair value | ||||||||
Investments at fair value | ||||||||
Investments at cost | ||||||||
Related-party investment | ||||||||
Deposits | ||||||||
Total assets | $ | $ | ||||||
Liabilities and stockholders’ deficit | ||||||||
Current liabilities | ||||||||
Accounts payable | $ | $ | ||||||
Accrued expenses | ||||||||
Secured credit facility, current | ||||||||
Loans payable, current | ||||||||
Contract liabilities | ||||||||
Promissory notes payable, current | ||||||||
Derivative liabilities | ||||||||
Customer deposits | ||||||||
Interest payable | ||||||||
Obligation under repurchase agreement | ||||||||
Total current liabilities | ||||||||
Loans payable | ||||||||
Promissory notes payable, net | ||||||||
Convertible notes payable | ||||||||
SAFE notes | ||||||||
Total liabilities | ||||||||
Commitments and contingencies (Note 15) | ||||||||
Stockholders’ deficit: | ||||||||
Series C Convertible Preferred Stock, $ | ||||||||
Series B Preferred Stock, $ ; | ||||||||
Series A Preferred Stock, $ ; | ||||||||
Series Seed Preferred Stock, $ ; | ||||||||
Common stock, $ par, | ||||||||
Additional paid-in capital | ||||||||
Treasury stock, | ( | ) | ||||||
Accumulated other comprehensive income | ||||||||
Accumulated deficit | ( | ) | ( | ) | ||||
Total Amass stockholders’ deficit | ( | ) | ( | ) | ||||
Non-controlling interest | ||||||||
Total stockholders’ deficit | ( | ) | ( | ) | ||||
Total liabilities and stockholders’ deficit | $ | $ | ||||||
| 2 |
Three months ended September 30, 2026 | Three months ended September 30, 2025 | Nine months ended September 30, 2026 | Nine months ended September 30, 2025 | |||||||||||||
Net revenues | ||||||||||||||||
Spirits & wine revenues | $ | $ | $ | $ | ||||||||||||
Other revenues | ||||||||||||||||
Total net revenues | ||||||||||||||||
Cost of net revenues | ||||||||||||||||
Cost of spirits & wine revenues | ||||||||||||||||
Cost of other revenues | ||||||||||||||||
Loss on contracts | ||||||||||||||||
Total cost of net revenues | ||||||||||||||||
Gross profit | ( | ) | ||||||||||||||
Operating expenses | ||||||||||||||||
Sales and marketing | ||||||||||||||||
General and administrative | ||||||||||||||||
Impairment loss | ||||||||||||||||
Total operating expenses | ||||||||||||||||
Loss from operations | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
Other income (expense) | ||||||||||||||||
Interest income | ||||||||||||||||
Interest expense | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
Change in fair value of derivative liabilities | ||||||||||||||||
Change in fair value of SAFEs | ( | ) | ( | ) | ||||||||||||
Unrealized loss on investment at fair value | ( | ) | ( | ) | ||||||||||||
Other income (expense), net | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
Total other income (expense) | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
Net loss | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
Net loss attributable to non-controlling interest | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
Net loss attributable to parent | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||
Deemed dividend on Series C Convertible Preferred Stock | ( | ) | ( | ) | ||||||||||||
Preferred Return on Series C Convertible Preferred Stock | ( | ) | ( | ) | ||||||||||||
Net loss attributable to common stockholders | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||
Weighted average common shares outstanding — basic and diluted | ||||||||||||||||
Net loss per common share — basic and diluted | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||
| 3 |
|
|
|
Preferred (Shares) |
|
|
Preferred (Amount) |
|
|
Common (Shares) |
|
|
Common (Amount) |
|
|
Additional Paid-in Capital |
|
|
Accumulated Other Comprehensive Income |
|
|
Accumulated Deficit |
|
|
Non-controlling Interest |
|
|
Total Stockholders’ Equity (Deficit) |
|
|||||||||
|
Balances at December 31, 2024 |
|
|
|
|
|
$ |
|
|
|
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
( |
) |
|
$ |
|
|
|
$ |
|
|
|
|
Exercise of stock options |
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
- |
|
|
|
|
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
Exercise of stock warrants |
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
Stock-based compensation - options |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
Warrants issued with promissory notes payable |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
Offering costs |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
( |
) |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
( |
) |
|
Net loss |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
|
Balances at March 31, 2025 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
( |
) |
|
|
|
|
|
|
|
|
|
Stock-based compensation - options |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
Issuance of Common Stock |
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
Offering costs |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
( |
) |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
( |
) |
|
Net loss |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
|
Balances at June 30, 2025 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
( |
) |
|
|
|
|
|
|
|
|
|
Stock-based compensation - Common Stock |
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
Issuance of Common Stock |
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
|
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
Exercise of stock options |
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
Stock-based compensation - options |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
Offering costs |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
( |
) |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
( |
) |
|
Net loss |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
|
Balances at September 30, 2025 |
|
|
|
|
|
$ |
|
|
|
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
( |
) |
|
$ |
|
|
|
$ |
|
|
|
|
|
|
Preferred (Shares) |
|
|
Preferred (Amount) |
|
|
Common (Shares) |
|
|
Common (Amount) |
|
|
Additional Paid-in Capital |
|
|
Treasury Stock (Shares) |
|
|
Treasury Stock (Amount) |
|
|
Accumulated Other Comprehensive Income |
|
|
Accumulated Deficit |
|
|
Non-controlling Interest |
|
|
Total Stockholders’ Equity (Deficit) |
|
|||||||||||
|
Balances at December 31, 2025 |
|
|
|
|
|
$ |
|
|
|
|
|
|
|
$ |
|
|
|
$ |
|
|
|
|
- |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
( |
) |
|
$ |
|
|
|
$ |
( |
) |
|
Issuance of Common Stock for services |
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
|
|
|
Exercise of stock options |
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
- |
|
|
|
|
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
|
|
|
Exercise of stock warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
|
|
|
Shares issued for extinguishment of interest payable |
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
|
|
|
Repurchase of Common Stock |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
( |
) |
|
|
( |
) |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
( |
) |
|
Stock-based compensation - options |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
|
|
|
Offering costs |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
( |
) |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
( |
) |
|
Net loss |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
|
Balances at March 31, 2026 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
( |
) |
|
|
( |
) |
|
|
|
|
|
|
( |
) |
|
|
|
|
|
|
( |
) |
|
Conversion of Preferred Stock to Common Stock |
|
|
( |
) |
|
|
( |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
Corrective issuance of Common Stock, net of cost |
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
|
|
|
Conversion of C onvertible N otes upon Direct Listing |
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
|
|
|
Exercise of stock warrants |
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
|
|
|
Exercise of stock options |
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
- |
|
|
|
|
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
|
|
|
Warrants issued in connection with Series C Convertible Preferred Stock |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
|
|
|
Issuance of Common Stock for services |
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
|
|
|
Stock-based compensation - options |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
|
|
|
Offering costs |
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
- |
|
|
|
( |
) |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
( |
) |
|
Warrant modifications |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
Net loss |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
|
Balances at June 30, 2026 |
|
|
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
( |
) |
|
|
( |
) |
|
|
|
|
|
|
( |
) |
|
|
|
|
|
|
|
|
|
Stock-based compensation - options |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
|
|
|
Offering costs |
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
- |
|
|
|
( |
) |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
( |
) |
|
Amendment of Series C Convertible Preferred Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
|
|
|
Issuance of Series C Convertible Preferred Stock, net |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
|
|
|
Conversion of Series C Convertible Preferred Stock into Common Stock |
|
|
( |
) |
|
|
( |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
Deemed dividend on Series C Convertible Preferred Stock |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
( |
) |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
( |
) |
|
Warrant modifications |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
Series B-3 Preferred Stock issuance inducement |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
( |
) |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
( |
) |
|
Net loss |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
|
Balances at September 30, 2026 |
|
|
|
|
|
$ |
|
|
|
|
|
|
|
$ |
|
|
|
$ |
|
|
|
|
( |
) |
|
$ |
( |
) |
|
$ |
|
|
|
$ |
( |
) |
|
$ |
|
|
|
$ |
( |
) |
| 4 |
Nine months ended September 30, 2026 | Nine months ended September 30, 2025 | |||||||
Cash flows from operating activities | - | - | ||||||
Net loss | $ | ( | ) | $ | ( | ) | ||
Adjustments to reconcile net loss to net cash used in operating activities | - | - | ||||||
Depreciation and amortization | ||||||||
Stock-based compensation | ||||||||
Common Stock issued for services | ||||||||
Amortization of debt discounts | ||||||||
Failed offering costs and write-off of deferred offering costs | ||||||||
Reserve for expected credit losses | ( | ) | ||||||
Impairment of intangible assets and investments | ||||||||
Change in fair value of derivative liabilities | ( | ) | ||||||
Change in fair value of SAFEs | ||||||||
Unrealized loss on investment at fair value | ||||||||
Inventory obsolescence | ||||||||
Loss on sale of securities at fair value | ||||||||
Loss on disposal of property and equipment | ||||||||
Loss on vendor settlement | ||||||||
Changes in operating assets and liabilities | - | - | ||||||
Accounts receivable | ( | ) | ||||||
Due from related parties | ( | ) | ||||||
Inventory, net | ( | ) | ||||||
Prepaid expenses and other current assets | ( | ) | ( | ) | ||||
Deposits | ( | ) | ||||||
Accounts payable | ( | ) | ||||||
Accrued expenses | ( | ) | ||||||
Interest receivable | ( | ) | ( | ) | ||||
Interest payable | ||||||||
Customer deposits | ( | ) | ||||||
Contract liabilities | ||||||||
Net cash used in operating activities | ( | ) | ( | ) | ||||
Cash flows from investing activities | - | - | ||||||
Advances to related parties | ( | ) | ( | ) | ||||
Proceeds from sale of investment | ||||||||
Proceeds from notes receivable | ||||||||
Purchase of related-party investment s | ( | ) | ||||||
Proceeds from disposal of property and equipment | ||||||||
Purchases of intangible assets | ( | ) | ||||||
Net cash (used in) provided by investing activities | ( | ) | ||||||
Cash flows from financing activities | - | - | ||||||
Proceeds from (repayments of) secured credit facility, n et | ( | ) | ||||||
Repayments of loans payable | ( | ) | ( | ) | ||||
Proceeds from promissory notes | ||||||||
Repayments of promissory notes | ( | ) | ||||||
Proceeds from convertible notes | ||||||||
Proceeds from issuance of Series C Convertible Preferred Stock and warrant | ||||||||
Proceeds from issuance of Common Stock | ||||||||
Offering costs | ( | ) | ( | ) | ||||
Proceeds from exercise of stock options | ||||||||
Proceeds from exercise of warrants | ||||||||
Repayment of obligation under repurchase agreement | ( | ) | ||||||
Net cash provided by financing activities | ||||||||
Net change in cash, cash equivalents and restricted cash | ||||||||
Cash, cash equivalents and restricted cash, beginning of the period | ||||||||
Cash, cash equivalents and restricted cash, end of the period | $ | $ | ||||||
Reconciliation of cash, cash equivalents and restricted cash to the balance sheets: | ||||||||
Cash and cash equivalents | ||||||||
Restricted cash | ||||||||
Total cash, cash equivalents and restricted cash | $ | $ | ||||||
Supplemental Disclosure of Cash Flow Information | - | - | ||||||
Cash paid for income taxes | ||||||||
Cash paid for interest | ||||||||
Noncash Investing and Financing Activities | - | - | ||||||
Transfer of investment for relief of debt | ||||||||
Warrants issued with promissory notes | ||||||||
Exchange of shareholder promissory note for convertible note | ||||||||
Conversion of Convertible Notes, accrued interest and related derivative liability into Common Stock | ||||||||
Common Stock issued as Series C commitment fee shares | ||||||||
Investment units transferred as Series B-3 Preferred Stock issuance inducement | ||||||||
Derivative recognized with Series C financing | ||||||||
Warrants issued with Series C Convertible Preferred Stock | ||||||||
Shares issued in extinguishment of accrued interest | ||||||||
Conversion of Series C Convertible Preferred Stock into Common Stock | ||||||||
Repurchase of Common Stock into treasury in settlement of advances to related parties | ||||||||
Warrant exercise proceeds applied to Secured Promissory Note principal | ||||||||
Deemed dividend on Series C Convertible Preferred Stock | ||||||||
Series C Convertible Preferred Stock derecognized on extinguishment | ||||||||
Discount from derivative liability | ||||||||
Derivative recognized on amendment of Series C Convertible Preferred Stock, net of derivative removed | ||||||||
Series C placement fee included in accounts payable | ||||||||
Reclassification of securities pledged as collateral to investments at fair value upon De Soi collateral release | ||||||||
Issuance of SAFE for reduction of promissory note principal | ||||||||
| 5 |
| 6 |
Three months ended September 30, 2026 | Nine months ended September 30, 2026 | |||||||
Customer A | ||||||||
Net Sales | % | % | ||||||
Accounts Receivable | % | % | ||||||
· | Level 1 – Quoted prices in active markets for identical assets or liabilities. |
· | Level 2 – Observable inputs (other than Level 1 quoted prices), such as quoted prices in active markets for similar assets or liabilities, quoted prices in markets that are not active for identical or similar assets or liabilities, or other inputs that are observable or can be corroborated by observable market data. |
· | Level 3 – Unobservable inputs that are supported by little or no market activity that are significant to determining the fair value of the assets or liabilities, including pricing models, discounted cash flow methodologies, and similar techniques. |
Investments at Fair Value / Securities Pledged as Collateral | Amount | |||
Balance, December 31, 2025 (securities pledged as collateral) | ||||
Reclassification upon release of collateral | ( | ) | ||
Transfer to investments at fair value upon release of collateral | ||||
Units transferred as Series B-3 Preferred Stock issuance inducement | ( | ) | ||
Change in fair value | ( | ) | ||
Balance, September 30, 2026 (investments at fair value) | $ | |||
Derivative Liabilities at Fair Value | Amount | |||
Balance, December 31, 2025 | ||||
Issuance of Convertible Notes and Warrants | ||||
Issuance of Series C Convertible Preferred Stock — conversion feature | ||||
Change in fair value | ( | ) | ||
Settlement upon conversion of Convertible Notes at the Direct Listing | ( | ) | ||
Derecognized on extinguishment of Series C Convertible Preferred Stock | ( | ) | ||
Recognized on extinguishment of Series C Convertible Preferred Stock (amended conversion feature) | ||||
Issued with Series C Convertible Preferred Stock at the Third Closing | ||||
Balance, September 30, 2026 | $ | |||
SAFEs at Fair Value | Amount | |||
Balance, December 31, 2025 | ||||
Change in fair value | ||||
Balance, September 30, 2026 | $ | |||
| 7 |
|
|
|
September 30, 2026
|
|
|
December 31, 2025
|
|
||
|
Raw materials
|
|
|
|
|
|
|
|
|
|
Work in process
|
|
|
|
|
|
|
|
|
|
Finished goods
|
|
|
|
|
|
|
|
|
|
Inventory reserve
|
|
|
(
|
)
|
|
|
(
|
)
|
|
Total inventory
|
|
$
|
|
|
|
$
|
|
|
|
|
|
September 30, 2026
|
|
|
December 31, 2025
|
|
||
|
Plant and equipment
|
|
|
|
|
|
|
|
|
|
Office and storage equipment
|
|
|
|
|
|
|
|
|
|
Furniture and fixtures
|
|
|
|
|
|
|
|
|
|
Leasehold improvements
|
|
|
|
|
|
|
|
|
|
Property and equipment, gross
|
|
|
|
|
|
|
|
|
|
Less: Accumulated depreciation and amortization
|
|
|
(
|
)
|
|
|
(
|
)
|
|
Property and equipment, net
|
|
$
|
|
|
|
$
|
|
|
|
|
|
September 30, 2026
|
|
|
December 31, 2025
|
|
||
|
Website development
|
|
|
|
|
|
|
|
|
|
Tradename/transferred IP
|
|
|
|
|
|
|
|
|
|
Customer base
|
|
|
|
|
|
|
|
|
|
Non-competes
|
|
|
|
|
|
|
|
|
|
Brand names
|
|
|
|
|
|
|
|
|
|
Intangible assets, gross
|
|
|
|
|
|
|
|
|
|
Less: Accumulated amortization
|
|
|
(
|
)
|
|
|
(
|
)
|
|
Intangible assets, net
|
|
$
|
|
|
|
$
|
|
|
|
Goodwill
|
|
$
|
|
|
|
$
|
|
|
| 8 |
| 9 |
| 10 |
| 11 |
| 12 |
| 13 |
September 30, 2026 Authorized | September 30, 2026 Outstanding | December 31, 2025 Authorized | December 31, 2025 Outstanding | |||||||||||||
Common Stock | ||||||||||||||||
Common Non-Voting Stock | ||||||||||||||||
Series Seed Preferred Stock (all sub-series) | ||||||||||||||||
Series A Preferred Stock | ||||||||||||||||
Series B Preferred Stock (all sub-series) | ||||||||||||||||
Series C Convertible Preferred Stock | ||||||||||||||||
| 14 |
Options | Weighted Average Exercise Price | Intrinsic Value | ||||||||||
Outstanding as of December 31, 2025 | $ | |||||||||||
Granted | ||||||||||||
Exercised | ( | ) | $ | |||||||||
Forfeited | ( | ) | $ | |||||||||
Outstanding as of September 30, 2026 | $ | $ | ||||||||||
Exercisable as of September 30, 2026 | $ | $ | ||||||||||
Shares | Weighted Average Exercise Price | |||||||
Outstanding as of December 31, 2025 | $ | |||||||
Granted | ||||||||
Exercised | ( | ) | ||||||
Cancelled or expired | ( | ) | ||||||
Outstanding as of September 30, 2026 | $ | |||||||
Exercisable as of September 30, 2026 | $ | |||||||
| 15 |
| 16 |
| 17 |
For the three months ended September 30, 2026 | Wine & Spirits | Non- Alcoholic and Functional | Total segment (a) | Unallocated amounts (b) | Comparable Adjustments (c) | Consolidated | ||||||||||||||||||
Net revenues | ||||||||||||||||||||||||
Cost of net revenues | ||||||||||||||||||||||||
Gross profit (d) | ( | ) | ( | ) | ||||||||||||||||||||
Sales and marketing | ||||||||||||||||||||||||
General and administrative | ||||||||||||||||||||||||
Impairment loss | ||||||||||||||||||||||||
Income (loss) from operations | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||||||||
Other income (expense) | ( | ) | ||||||||||||||||||||||
Loss before income taxes | ( | ) | ||||||||||||||||||||||
For the three months ended September 30, 2025 | Wine & Spirits | Non- Alcoholic and Functional | Total segment (a) | Unallocated amounts (b) | Comparable Adjustments (c) | Consolidated | ||||||||||||||||||
Net revenues | ||||||||||||||||||||||||
Cost of net revenues | ||||||||||||||||||||||||
Gross profit (d) | ( | ) | ||||||||||||||||||||||
Sales and marketing | ||||||||||||||||||||||||
General and administrative | ||||||||||||||||||||||||
Impairment loss | ||||||||||||||||||||||||
Income (loss) from operations | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||||||
Other income (expense) | ( | ) | ||||||||||||||||||||||
Loss before income taxes | ( | ) | ||||||||||||||||||||||
| 18 |
For the nine months ended September 30, 2026 | Wine & Spirits | Non- Alcoholic and Functional | Total segment (a) | Unallocated amounts (b) | Comparable Adjustments (c) | Consolidated | ||||||||||||||||||
Net revenues | ||||||||||||||||||||||||
Cost of net revenues | ||||||||||||||||||||||||
Gross profit (d) | ( | ) | ||||||||||||||||||||||
Sales and marketing | ||||||||||||||||||||||||
General and administrative | ||||||||||||||||||||||||
Impairment loss | ||||||||||||||||||||||||
Loss from operations | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||||||
Other income (expense) | ( | ) | ||||||||||||||||||||||
Loss before income taxes | ( | ) | ||||||||||||||||||||||
For the nine months ended September 30, 2025 | Wine & Spirits | Non- Alcoholic and Functional | Total segment (a) | Unallocated amounts (b) | Comparable Adjustments (c) | Consolidated | ||||||||||||||||||
Net revenues | ||||||||||||||||||||||||
Cost of net revenues | ( | ) | ||||||||||||||||||||||
Gross profit (d) | ( | ) | ||||||||||||||||||||||
Sales and marketing | ||||||||||||||||||||||||
General and administrative | ||||||||||||||||||||||||
Impairment loss | ||||||||||||||||||||||||
Loss from operations | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||||||
Other income (expense) | ( | ) | ||||||||||||||||||||||
Loss before income taxes | ( | ) | ||||||||||||||||||||||
(a) | Segment amounts are derived from the Company’s entity- and brand-level general ledger reporting: the Non-Alcoholic and Functional segment reflects the Good Twin brand activity and the Amass Electrolyte entity; the Wine & Spirits segment reflects the remaining operating entities. |
(b) | Unallocated amounts include costs held in the corporate infrastructure that are not allocated to any reporting segment and the shared-services fees charged to Afterdream, a related party (see Note 14), which are presented in net revenues. |
(c) | Comparable Adjustments are items that management excludes from segment results because they are not reflective of current operations. For 2026 they comprise the August 2026 sale of bulk wine to Full Glass and its cost, the provision for losses on bulk wine purchase commitments and the write-down of the remaining bulk wine the Company has agreed to sell to Full Glass, all recorded in the third quarter of 2026, stock-based compensation and impairment losses; for 2025 they comprise bulk wine sales and related costs and storage, the loss on bulk wine purchase commitments recognized in the third quarter of 2025, stock-based compensation and the impairment loss recognized in the third quarter of 2025. |
(d) | Segment gross profit is reconciled to gross profit on the consolidated statement of operations with the inclusion of unallocated amounts and Comparable Adjustments. |
Three months ended September 30, 2026 | Three months ended September 30, 2025 | Nine months ended September 30, 2026 | Nine months ended September 30, 2025 | |||||||||||||
Net revenues — sales of bulk wine (a) | ||||||||||||||||
Cost of net revenues — bulk wine and write-downs (a) | ||||||||||||||||
General and administrative — stock-based compensation (b) | ||||||||||||||||
General and administrative — storage on bulk wine (a) | ( | ) | ||||||||||||||
Impairment loss (b) | ||||||||||||||||
Comparable adjustments, Operating loss | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
(a) | Sales of excess bulk wine and the related costs and storage are not part of the Company’s regular operations and are excluded from the CODM’s review. For the third quarter of 2026, (a) also includes the bulk wine items listed above, and for the third quarter of 2025 it includes a $ |
(b) | The CODM does not consider stock-based compensation or impairment losses in evaluating segment performance. |
| 19 |
Three months ended September 30, 2026 | Three months ended September 30, 2025 | Nine months ended September 30, 2026 | Nine months ended September 30, 2025 | |||||||||||||
Net revenues | ||||||||||||||||
U.S. | ||||||||||||||||
Non-U.S. | ||||||||||||||||
Total net revenues | $ | $ | $ | $ | ||||||||||||
| 20 |
| 21 |
· | Streeterville Series C Convertible Preferred Stock (August–October 2026). On August 19, 2026, we amended the terms of the Series C Convertible Preferred Stock. We accounted for the amendment as an extinguishment, recorded a deemed dividend of approximately $5.7 million that did not affect net loss, and moved the stock from mezzanine equity to permanent equity. On August 21, 2026, we issued 2,000 shares of Series C Convertible Preferred Stock to Streeterville for $2,000,000 (the “Third Closing”). On September 23, 2026, Streeterville converted 175 shares into 253,624 shares of common stock at $0.75 per share. On October 22, 2026, we filed a Second Amended and Restated Certificate of Designation that reduces the Floor Price from $4.00 to $1.00 per share and removes the $0.75 minimum price on Limited Conversions, which could result in greater dilution to existing stockholders, and we and Streeterville terminated the warrant to purchase up to 3,500,000 shares of common stock with no payment. See Notes 12 and 17. |
· | Nasdaq continued-listing notices; Series C Trigger Event (July and October 2026). On July 22, 2026, we received notices from Nasdaq stating that we are not in compliance with the minimum Market Value of Listed Securities and minimum Market Value of Publicly Held Shares requirements for continued listing on the Nasdaq Global Market, with a 180-calendar-day period, through January 19, 2027, to regain compliance. On October 9, 2026, we received a further notice that the closing bid price of our common stock had been below $1.00 per share for 30 consecutive business days and that we are not in compliance with the minimum bid price requirement, with a 180-calendar-day grace period through April 7, 2027 to regain compliance. Receipt of the notices constituted a Trigger Event under the Series C Certificate of Designation, permitting conversions of the Series C Convertible Preferred Stock at the alternate conversion price described under “Liquidity and capital resources” below. In addition, the Preferred Return on the Series C Convertible Preferred Stock for the second and third quarters of 2026 was not paid, the $200,000 Mezzanine Secured Notes are past due, and $0.55 million of our promissory notes had passed their maturity dates and had not been repaid at September 30, 2026 ($1.25 million as of the date of this Report). See Notes 9, 12 and 17 to our unaudited condensed consolidated financial statements. |
· | Full Glass Side Letter Agreement (July 2026). In July 2026, we entered into a Side Letter Agreement with Full Glass that replaced Full Glass’s remaining $4.0 million purchase obligation with a $427,000 settlement, of which $406,000 is a deposit that Full Glass may apply toward the redemption of our units in Full Glass. See Note 6. |
· | Brand transfer term sheet (October 2026). In October 2026, we signed a term sheet, non-binding except for certain provisions, to transfer certain of our wine brands, and the related inventory, to one of our bulk wine suppliers. In exchange, the supplier would cancel all amounts we owe it, and we would issue an $850,000 promissory note. Separately, and whether or not the transaction closes, we would issue 600,000 shares of common stock to the supplier for a $300,000 credit against the amounts we owe. The transaction is subject to definitive agreements and to required consents. If it has not closed by December 31, 2026, other than because of the supplier, the amounts we owe the supplier become due on January 1, 2027. See Notes 5, 7 and 17. |
· | Chief Financial Officer transition (October 2026). On October 23, 2026, we reported that Zachary Ament will resign as Chief Financial Officer effective November 16, 2026. His resignation did not result from any disagreement with the Company. Geoff McFarlane, a related party (see Note 14 to our unaudited condensed consolidated financial statements), will serve as Interim Chief Financial Officer and principal financial and accounting officer beginning November 17, 2026. |
| 22 |
Three months ended September 30, 2026 | Three months ended September 30, 2025 | Dollar Change | Percent Change | |||||||||||||
Net revenue | 5,368,515 | 4,067,106 | 1,301,409 | 32 | % | |||||||||||
Cost of net revenue | 5,907,886 | 3,730,441 | 2,177,445 | 58 | % | |||||||||||
Gross profit | (539,371 | ) | 336,665 | (876,036 | ) | -260 | % | |||||||||
Sales and marketing | 1,102,055 | 799,075 | 302,980 | 38 | % | |||||||||||
General and administrative | 1,920,217 | 1,918,149 | 2,068 | 0 | % | |||||||||||
Impairment loss | 1,100,531 | 6,064,603 | (4,964,072 | ) | -82 | % | ||||||||||
Total operating expenses | 4, 122,803 | 8,781,827 | (4, 659,024 | ) | - 53 | % | ||||||||||
Loss from operations | ( 4,662,174 | ) | (8,445,162 | ) | 3,782,988 | 45 | % | |||||||||
Other income (expense) | (1,063,609 | ) | (455,465 | ) | (608,144 | ) | -134 | % | ||||||||
Net loss | ( 5,725,783 | ) | (8,900,627 | ) | 3,174,844 | 36 | % | |||||||||
Nine months ended September 30, 2026 | Nine months ended September 30, 2025 | Dollar Change | Percent Change | |||||||||||||||
Net revenue | 15,110,602 | 13,912,481 | 1,198,121 | 9 | % | |||||||||||||
Cost of net revenue | 13,081,482 | 10,216,504 | 2,864,978 | 28 | % | |||||||||||||
Gross profit | 2,029,120 | 3,695,977 | (1,666,857 | ) | -45 | % | ||||||||||||
Sales and marketing | 3,129,409 | 2,768,855 | 360,554 | 13 | % | |||||||||||||
General and administrative | 10, 491,210 | 5,953,441 | 4, 537,769 | 76 | % | |||||||||||||
Impairment loss | 1,550,216 | 6,064,603 | (4,514,387 | ) | -74 | % | ||||||||||||
Total operating expenses | 15, 170,835 | 14,786,899 | 383,936 | 3 | % | |||||||||||||
Loss from operations | (13, 141,715 | ) | (11,090,922 | ) | (2,050,793 | ) | -18 | % | ||||||||||
Other income (expense) | (3,174,888 | ) | (2,794,749 | ) | (380,139 | ) | -14 | % | ||||||||||
Net loss | (16, 316,603 | ) | (13,885,671 | ) | (2,430,932 | ) | -18 | % | ||||||||||
Three months ended September 30, 2026 | Three months ended September 30, 2025 | Nine months ended September 30, 2026 | Nine months ended September 30, 2025 | |||||||||||||
Net revenues | ||||||||||||||||
Sales of bulk wine (a) | 38,270 | - | 38,270 | 128,736 | ||||||||||||
Comparable adjustments, Net revenues | 38,270 | - | 38,270 | 128,736 | ||||||||||||
Cost of net revenues | ||||||||||||||||
Cost of sales of bulk wine (a) | 306,057 | - | 306,057 | 146,565 | ||||||||||||
Provision for losses on bulk wine purchase commitments and write-down of bulk wine (a) | 2,172,125 | 124,476 | 2,172,125 | 124,476 | ||||||||||||
Cost of write-down of unutilized wine pre-acquisition (b) | - | - | - | 168,930 | ||||||||||||
Comparable adjustments, Cost of net revenues | 2,478,182 | 124,476 | 2,478,182 | 439,971 | ||||||||||||
General and administrative | ||||||||||||||||
Stock-based compensation (c) | 90,255 | 159,708 | 537,800 | 381,172 | ||||||||||||
Storage on bulk wine (a) | - | (43,838 | ) | - | 102,506 | |||||||||||
Comparable adjustments, general and administrative | 90,255 | 115,870 | 537,800 | 483,678 | ||||||||||||
Impairment loss (d) | 1,100,531 | 6,064,603 | 1,550,216 | 6,064,603 | ||||||||||||
Comparable adjustments, Operating loss | (3, 630,698 | ) | (6,304,949 | ) | (4,527,928 | ) | (6,859,516 | ) | ||||||||
| 23 |
Three months ended September 30, 2026 | Three months ended September 30, 2025 | Dollar Change | Percent Change | |||||||||||||
Wine & Spirits | 4,644,092 | 3,930,060 | 714,032 | 18 | % | |||||||||||
Non-Alcoholic and Functional | 641,153 | 122,046 | 519,107 | 425 | % | |||||||||||
Unallocated amounts | 45,000 | 15,000 | 30,000 | 200 | % | |||||||||||
Comparable adjustments | 38,270 | - | 38,270 | n/m | ||||||||||||
Consolidated net revenues | 5,368,515 | 4,067,106 | 1,301,409 | 32 | % | |||||||||||
Nine months ended September 30, 2026 | Nine months ended September 30, 2025 | Dollar Change | Percent Change | |||||||||||||
Wine & Spirits | 13,453,231 | 13,236,677 | 216,554 | 2 | % | |||||||||||
Non-Alcoholic and Functional | 1,574,101 | 522,068 | 1,052,033 | 202 | % | |||||||||||
Unallocated amounts | 45,000 | 25,000 | 20,000 | 80 | % | |||||||||||
Comparable adjustments | 38,270 | 128,736 | (90,466 | ) | -70 | % | ||||||||||
Consolidated net revenues | 15,110,602 | 13,912,481 | 1,198,121 | 9 | % | |||||||||||
Three months ended September 30, 2026 | Three months ended September 30, 2025 | Dollar Change | Percent Change | |||||||||||||
Core brands | 3,815,543 | 2,283,484 | 1,532,059 | 67 | % | |||||||||||
Other brands | 1,624,924 | 1,684,526 | (59,602 | ) | -4 | % | ||||||||||
Discontinued brands | 95,973 | 276,294 | (180,321 | ) | -65 | % | ||||||||||
Revenue attributable to brands | 5,536,440 | 4,244,304 | 1,292,136 | 30 | % | |||||||||||
Trade spend and other amounts not attributed to a brand | (167,925 | ) | (177,198 | ) | 9,273 | 5 | % | |||||||||
Consolidated net revenues | 5, 368,515 | 4,067,106 | 1, 301,409 | 32 | % | |||||||||||
| 24 |
Nine months ended September 30, 2026 | Nine months ended September 30, 2025 | Dollar Change | Percent Change | |||||||||||||
Core brands | 10,259,416 | 8,065,924 | 2,193,492 | 27 | % | |||||||||||
Other brands | 4,977, 525 | 5,261,489 | (283,964 | ) | -5 | % | ||||||||||
Discontinued brands | 433,619 | 1,023,298 | (589,679 | ) | -58 | % | ||||||||||
Revenue attributable to brands | 15,670, 560 | 14,350,711 | 1,319, 849 | 9 | % | |||||||||||
Trade spend and other amounts not attributed to a brand | (559,958 | ) | (438,230 | ) | (121,728 | ) | -28 | % | ||||||||
Consolidated net revenues | 15, 110,602 | 13,912,481 | 1, 198,121 | 9 | % | |||||||||||
Three months ended September 30, 2026 | Three months ended September 30, 2025 | Nine months ended September 30, 2026 | Nine months ended September 30, 2025 | |||||||||||||
Direct-to-consumer and e-commerce | 216,558 | 28,833 | 544,096 | 106,830 | ||||||||||||
Wholesale and other | 5, 151,957 | 4,038,273 | 14, 566,506 | 13,805,651 | ||||||||||||
Consolidated net revenues | 5, 368,515 | 4,067,106 | 15, 110,602 | 13,912,481 | ||||||||||||
| 25 |
Three months ended September 30, 2026 | Three months ended September 30, 2025 | Dollar Change | Percent Change | |||||||||||||
Wine & Spirits | 1,692,593 | 415,068 | 1,277,525 | 308 | % | |||||||||||
Non-Alcoholic and Functional | 162,948 | 31,073 | 131,875 | 424 | % | |||||||||||
Unallocated amounts | 45,000 | 15,000 | 30,000 | 200 | % | |||||||||||
Comparable adjustments | (2,439,912 | ) | (124,476 | ) | (2,315,436 | ) | -1,860 | % | ||||||||
Consolidated gross profit | (539,371 | ) | 336,665 | (876,036 | ) | -260 | % | |||||||||
Nine months ended September 30, 2026 | Nine months ended September 30, 2025 | Dollar Change | Percent Change | |||||||||||||
Wine & Spirits | 4,055,464 | 3,815,357 | 240,107 | 6 | % | |||||||||||
Non-Alcoholic and Functional | 368,568 | 166,806 | 201,762 | 121 | % | |||||||||||
Unallocated amounts | 45,000 | 25,049 | 19,951 | 80 | % | |||||||||||
Comparable adjustments | (2,439,912 | ) | (311,235 | ) | (2,128,677 | ) | -684 | % | ||||||||
Consolidated gross profit | 2,029,120 | 3,695,977 | (1,666,857 | ) | -45 | % | ||||||||||
Three months ended September 30, 2026 | Three months ended September 30, 2025 | Nine months ended September 30, 2026 | Nine months ended September 30, 2025 | |||||||||||||
Direct-to-consumer and e-commerce gross profit | 21,625 | 6,455 | 60,715 | 46,306 | ||||||||||||
Gross margin | 10.0 | % | 22.4 | % | 11.2 | % | 43.3 | % | ||||||||
Wholesale and other gross profit | 1,346,140 | 1,265,260 | 4,374,231 | 4,761,292 | ||||||||||||
Gross margin | 26.1 | % | 31.3 | % | 30.0 | % | 34.5 | % | ||||||||
Inventory write-downs and other costs not attributed to a channel | (1,907,136 | ) | (935,050 | ) | (2,405,826 | ) | (1,111,621 | ) | ||||||||
Total gross profit | (539,371 | ) | 336,665 | 2,029,120 | 3,695,977 | |||||||||||
| 26 |
Three months ended September 30, 2026 | Three months ended September 30, 2025 | Nine months ended September 30, 2026 | Nine months ended September 30, 2025 | |||||||||||||
Core brands product margin | 1,556,093 | 950,869 | 4,238,329 | 3,428,084 | ||||||||||||
Product margin percentage | 40.8 | % | 41.6 | % | 41.3 | % | 42.5 | % | ||||||||
Other brands product margin | 406,741 | 617,011 | 1,112,351 | 1,992,133 | ||||||||||||
Product margin percentage | 25.0 | % | 36.6 | % | 22.3 | % | 37.9 | % | ||||||||
Discontinued brands product margin | 30,822 | 11,435 | 121,025 | 180,947 | ||||||||||||
Product margin percentage | 32.1 | % | 4.1 | % | 27.9 | % | 17.7 | % | ||||||||
Trade spend and costs not attributed to individual items | (2,533,027 | ) | (1,242,650 | ) | (3,442,585 | ) | (1,905,187 | ) | ||||||||
Total gross profit | (539,371 | ) | 336,665 | 2,029,120 | 3,695,977 | |||||||||||
Three months ended September 30, 2026 | Three months ended September 30, 2025 | Nine months ended September 30, 2026 | Nine months ended September 30, 2025 | |||||||||||||
Consolidated gross profit | (539,371 | ) | 336,665 | 2,029,120 | 3,695,977 | |||||||||||
Gross margin | -10.0 | % | 8.3 | % | 13.4 | % | 26.6 | % | ||||||||
Inventory write-downs and variance, net | 1,907,136 | 935,050 | 2,175,288 | 1,103,980 | ||||||||||||
Bulk wine, net | 267,946 | - | 267,946 | 17,829 | ||||||||||||
Adjusted gross profit, non-GAAP | 1,635,711 | 1,271,715 | 4,472,354 | 4,817,786 | ||||||||||||
Adjusted gross margin | 30.5 | % | 31.3 | % | 29.6 | % | 34.6 | % | ||||||||
| 27 |
Three months ended September 30, 2026 | Three months ended September 30, 2025 | Dollar Change | Percent Change | |||||||||||||
Wine & Spirits | 692,571 | 766,677 | (74,106 | ) | -10 | % | ||||||||||
Non-Alcoholic and Functional | 348,367 | 32,188 | 316,179 | 982 | % | |||||||||||
Unallocated amounts | 61,117 | 210 | 60,907 | n/m | ||||||||||||
Comparable adjustments | - | - | - | n/m | ||||||||||||
Consolidated sales and marketing | 1,102,055 | 799,075 | 302,980 | 38 | % | |||||||||||
Nine months ended September 30, 2026 | Nine months ended September 30, 2025 | Dollar Change | Percent Change | |||||||||||||
Wine & Spirits | 2,194,085 | 2,607,066 | (412,981 | ) | -16 | % | ||||||||||
Non-Alcoholic and Functional | 794,545 | 149,874 | 644,671 | 430 | % | |||||||||||
Unallocated amounts | 140,779 | 11,915 | 128,864 | 1,082 | % | |||||||||||
Comparable adjustments | - | - | - | n/m | ||||||||||||
Consolidated sales and marketing | 3,129,409 | 2,768,855 | 360,554 | 13 | % | |||||||||||
Three months ended September 30, 2026 | Three months ended September 30, 2025 | Dollar Change | Percent Change | |||||||||||||
Wine & Spirits | 780,362 | 1,042,957 | (262,595 | ) | -25 | % | ||||||||||
Non-Alcoholic and Functional | 378,715 | 37,379 | 341,336 | 913 | % | |||||||||||
Unallocated amounts | 670,885 | 721,943 | (51,058 | ) | -7 | % | ||||||||||
Comparable adjustments | 90,255 | 115,870 | (25,615 | ) | -22 | % | ||||||||||
Consolidated general and administrative | 1,920,217 | 1,918,149 | 2,068 | 0 | % | |||||||||||
Nine months ended September 30, 2026 | Nine months ended September 30, 2025 | Dollar Change | Percent Change | |||||||||||||
Wine & Spirits | 2,547,146 | 3,429,177 | (882,031 | ) | -26 | % | ||||||||||
Non-Alcoholic and Functional | 708,105 | 137,360 | 570,745 | 416 | % | |||||||||||
Unallocated amounts | 6,698,159 | 1,903,226 | 4,794,933 | 252 | % | |||||||||||
Comparable adjustments | 537,800 | 483,678 | 54,122 | 11 | % | |||||||||||
Consolidated general and administrative | 10, 491,210 | 5,953,441 | 4, 537,769 | 76 | % | |||||||||||
| 28 |
Three months ended September 30, 2026 | Three months ended September 30, 2025 | Dollar Change | Percent Change | |||||||||||||
Wine & Spirits | 219,660 | (1,394,566 | ) | 1,614,226 | 116 | % | ||||||||||
Non-Alcoholic and Functional | (564,134 | ) | (38,494 | ) | (525,640 | ) | -1,366 | % | ||||||||
Unallocated amounts | ( 687,002 | ) | (707,153 | ) | 20,151 | 3 | % | |||||||||
Comparable adjustments | (3, 630,698 | ) | (6,304,949 | ) | 2,674,251 | 42 | % | |||||||||
Consolidated operating loss | (4,662,174 | ) | (8,445,162 | ) | 3,782,988 | 45 | % | |||||||||
Nine months ended September 30, 2026 | Nine months ended September 30, 2025 | Dollar Change | Percent Change | |||||||||||||
Wine & Spirits | (685,767 | ) | (2,220,886 | ) | 1,535,119 | 69 | % | |||||||||
Non-Alcoholic and Functional | (1,134,082 | ) | (120,428 | ) | (1,013,654 | ) | -842 | % | ||||||||
Unallocated amounts | (6,793,938 | ) | (1,890,092 | ) | (4,903,846 | ) | -259 | % | ||||||||
Comparable adjustments | (4, 527,928 | ) | (6,859,516 | ) | 2,331,588 | 34 | % | |||||||||
Consolidated operating loss | (13, 141,715 | ) | (11,090,922 | ) | (2,050,793 | ) | -18 | % | ||||||||
Three months ended September 30, 2026 | Three months ended September 30, 2025 | Nine months ended September 30, 2026 | Nine months ended September 30, 2025 | |||||||||||||
Net loss | ( 5,725,783 | ) | (8,900,627 | ) | (16,316,603 | ) | (13,885,671 | ) | ||||||||
Interest expense | 374,170 | 448,333 | 2,166,072 | 2,484,585 | ||||||||||||
Interest income | (71,849 | ) | (49,850 | ) | (75,558 | ) | (84,085 | ) | ||||||||
Provision for income taxes | - | - | - | - | ||||||||||||
Depreciation and amortization | 130,562 | 168,940 | 400,169 | 504,078 | ||||||||||||
EBITDA | (5, 292,900 | ) | (8,333,204 | ) | (13,825,920 | ) | (10,981,093 | ) | ||||||||
One-off deal and direct-listing costs | (384,516 | ) | - | 1,013,849 | - | |||||||||||
Write-off of deferred offering costs | 1,184,271 | - | 1,698,584 | - | ||||||||||||
Stock-based compensation | 90,255 | 159,708 | 537,800 | 381,172 | ||||||||||||
Impairment loss and bad debt, net | 1,139,426 | 6,072,467 | 1,606,974 | 6,062,169 | ||||||||||||
Change in fair value of derivative liabilities | (1,011,183 | ) | - | (1,198,936 | ) | - | ||||||||||
Change in fair value of SAFEs | 10,848 | - | 31,910 | - | ||||||||||||
Stock-settled banker and advisory fees | - | 416,105 | 2,631,800 | 416,105 | ||||||||||||
Bulk wine, net | 267,946 | - | 267,946 | 17,829 | ||||||||||||
Inventory write-downs and variance, net | 1,907,136 | 935,050 | 2,175,288 | 1,103,980 | ||||||||||||
Juice storage | 13,952 | 95,398 | 10,440 | 644,137 | ||||||||||||
Merchant and factoring fees | 4,008 | 27,937 | 28,943 | 49,958 | ||||||||||||
One-time items, net | 162,652 | (15,000 | ) | 50,789 | (15,000 | ) | ||||||||||
Total adjustments | 3,384,795 | 7,691,665 | 8,855,387 | 8,660,350 | ||||||||||||
Adjusted EBITDA | (1,908,105 | ) | (641,539 | ) | (4,970,533 | ) | (2,320,743 | ) | ||||||||
| 29 |
Three months ended September 30, 2026 | Three months ended September 30, 2025 | Dollar Change | Percent Change | |||||||||||||
Interest income | 71,849 | 49,850 | 21,999 | 44 | % | |||||||||||
Interest expense | (374,170 | ) | (448,333 | ) | 74,163 | 17 | % | |||||||||
Change in fair value of derivative liabilities | 1,011,183 | - | 1,011,183 | n/m | ||||||||||||
Change in fair value of SAFEs | (10,848 | ) | - | (10,848 | ) | n/m | ||||||||||
Unrealized loss on investment at fair value | (433,764 | ) | - | (433,764 | ) | n/m | ||||||||||
Other income (expense), net | (1, 327,859 | ) | (56,982 | ) | (1, 270,877 | ) | -2, 230 | % | ||||||||
Consolidated other income (expense) | (1,063,609 | ) | (455,465 | ) | (608,144 | ) | -134 | % | ||||||||
Nine months ended September 30, 2026 | Nine months ended September 30, 2025 | Dollar Change | Percent Change | |||||||||||||
Interest income | 75,558 | 84,085 | (8,527 | ) | -10 | % | ||||||||||
Interest expense | (2,166,072 | ) | (2,484,585 | ) | 318,513 | 13 | % | |||||||||
Change in fair value of derivative liabilities | 1,198,936 | - | 1,198,936 | n/m | ||||||||||||
Change in fair value of SAFEs | (31,910 | ) | - | (31,910 | ) | n/m | ||||||||||
Unrealized loss on investment at fair value | (433,764 | ) | - | (433,764 | ) | n/m | ||||||||||
Other income (expense), net | ( 1,817,636 | ) | (394,249 | ) | (1, 423,387 | ) | - 361 | % | ||||||||
Consolidated other income (expense) | (3,174,888 | ) | (2,794,749 | ) | (380,139 | ) | -14 | % | ||||||||
| 30 |
Nine months ended September 30, 2026 | Nine months ended September 30, 2025 | Dollar Change | ||||||||||
Net cash used in operating activities | (7,612,731 | ) | (822,955 | ) | (6,789,776 | ) | ||||||
Net cash (used in) provided by investing activities | (1,790,427 | ) | 743,945 | (2,534,372 | ) | |||||||
Net cash provided by (used in) financing activities | 9,502,133 | 216,777 | 9,285,356 | |||||||||
Net change in cash, cash equivalents and restricted cash | 98,975 | 137,767 | (38,792 | ) | ||||||||
| 31 |
Category | Next 12 Months | Thereafter | Total | |||||||||
Secured credit facility principal and interest (1) | $ | 3,912 | $ | — | $ | 3,912 | ||||||
Other debt principal and interest (2) | 3,035 | 165 | 3,200 | |||||||||
SAFEs and convertible instruments (3) | — | 552 | 552 | |||||||||
Leases and licensing fees (4) | 127 | — | 127 | |||||||||
Supplier and other operating payables (5) | 5, 233 | — | 5, 233 | |||||||||
Professional service payables (6) | 6, 039 | — | 6, 039 | |||||||||
Bulk wine purchase commitments (7) | 6,083 | 3,544 | 9,627 | |||||||||
Total material cash requirements | $ | 24,429 | $ | 4,261 | $ | 28,690 | ||||||
| 32 |
| 33 |
| 34 |
| 35 |
· | Absence of a comprehensive and formalized accounting and financial reporting policies and procedures manual. We did not have a comprehensive and formalized accounting and financial reporting policies and procedures manual sufficient to ensure accurate and timely financial reporting, including with respect to periodic and year-end closing procedures, accrual and cutoff of accounts receivable and accounts payable, reconciliation of significant accounts, the establishment and review of accounting estimates, the preparation and review of closing and recurring journal entries, the documentation of the responsibilities of accounting personnel and management review procedures, and the design and maintenance of effective controls over information technology systems relevant to the preparation of financial statements. |
· | Insufficient segregation of duties. Certain controls were concentrated in a small number of employees and members of management, primarily as a result of our size, which prevented appropriate segregation of duties and could amplify the risk arising from related party transactions. We also had not adopted a formal approval matrix establishing authorization limits for transactions and journal entries. |
· | Ineffective controls over complex and non-routine transactions. We did not design and maintain effective controls over the identification, technical accounting evaluation and review of complex and non-routine transactions, including equity and financing transactions, on a timely basis. |
· | developing, adopting and maintaining a comprehensive accounting policies and procedures manual documenting our significant accounting policies in accordance with U.S. GAAP; |
· | establishing formalized month-end, quarter-end and year-end closing procedures and checklists, including standardized close calendars, account reconciliation requirements, materiality thresholds and reviewer sign-offs; |
| 36 |
· | designing and implementing formal management review controls, including variance analysis and independent review and approval of manual, non-routine and related party journal entries; |
· | assessing and enhancing information technology general controls over our financial reporting systems, including user access provisioning and deprovisioning and change management controls; and |
· | performing a financial reporting risk assessment, including a fraud risk assessment, and mapping identified risks to specific controls. |
· | assessing our accounting organization and developing a formal segregation of duties matrix to identify and resolve conflicting responsibilities; |
· | preparing formal role descriptions and authorization limits, and adding or reallocating personnel as necessary so that a secondary party reviews and/or approves transactions across all significant processes; |
· | establishing a formal policy and process for the identification, approval, review and monitoring of related party transactions, including Audit Committee or independent director pre-approval; |
· | reviewing and configuring user roles and permissions within our enterprise resource planning system to enforce segregation of duties; and |
· | implementing compensating controls, including independent Chief Financial Officer review and approval of journal entries and dual-authorization requirements for disbursements above defined thresholds, together with ongoing monitoring and periodic reporting to the Audit Committee. |
· | preparing technical accounting memoranda for complex and non-routine transactions, including equity and financing transactions, reviewed and approved by the Chief Financial Officer before the transactions are recorded; and |
· | engaging third-party technical accounting advisors to assist with the evaluation of such transactions. |
| 37 |
· | a limited availability of market quotations for our securities; |
· | reduced liquidity for our securities; |
· | a determination that our common stock is a “penny stock” which will require brokers trading in our Common Stock to adhere to more stringent rules and possibly result in a reduced level of trading activity in the secondary trading market for our securities; |
· | a limited amount of news and analyst coverage; and |
· | a decreased ability to issue additional securities or obtain additional financing in the future. |
| 38 |
| 39 |
Exhibit No. | Description | |
3.1 | Eighth Amended and Restated Certificate of Incorporation (Incorporated by Reference to Exhibit 3.1 to Amendment No. 2 to the Company’s Registration Statement on Form S-1 (File No. 333-294941), filed with the SEC on April 30, 2026). | |
3.2 | Bylaws (Incorporated by Reference to Exhibit 3.2 to the Company’s Registration Statement on Form S-1 (File No. 333-294941), filed with the SEC on April 9, 2026). | |
3.3 | Certificate of Designation of Preferences and Rights of Series C Convertible Preferred Stock (Incorporated by Reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K, filed with the SEC on May 20, 2026). | |
3.4 | Amended and Restated Certificate of Designation of Preferences and Rights of Series C Convertible Preferred Stock (Incorporated by Reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K, filed with the SEC on August 21, 2026). | |
3.5 | Second Amended and Restated Certificate of Designation of Preferences and Rights of Series C Convertible Preferred Stock (Incorporated by Reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K, filed with the SEC on October 23, 2026). | |
3.6 | Amendment No. 1 to the Bylaws of AMASS Brands Inc. (Incorporated by Reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K, filed with the SEC on October 29, 2026). | |
4.1 | Amendment No. 3 to the Warrant to Purchase Shares of Common Stock, dated July 10, 2026 (Incorporated by Reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K, filed with the SEC on July 10, 2026). | |
10.1 | Side Letter Agreement, dated July 29, 2026, by and among Full Glass Wine Co., LLC, Full Glass – Licensing, LLC and AMASS Brands Inc. (Incorporated by Reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K, filed with the SEC on August 5, 2026). | |
10.2 | Warrant Termination Agreement, dated October 22, 2026, between AMASS Brands Inc. and Streeterville Capital, LLC (Incorporated by Reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K, filed with the SEC on October 23, 2026). | |
31.1 | Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rule 13a-14(a) or 15d-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith). | |
32.1 | Certification of Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith). | |
101.INS | Inline XBRL Instance Document. | |
101.SCH | Inline XBRL Taxonomy Extension Schema Document. | |
101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document. | |
101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document. | |
101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document. | |
101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document. | |
104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). |
| 40 |
AMASS Brands Inc. | ||
By: | /s/ Mark T. Lynn | |
Mark T. Lynn | ||
Chief Executive Officer | ||
(Principal Executive Officer) | ||
By: | /s/ Mark T. Lynn | |
Mark T. Lynn | ||
Acting Chief Financial Officer | ||
(Principal Financial and Accounting Officer) | ||
| 41 |